BEHANDLUNG VON TYP 2-DIABETES MIT FTY720

European patent · EP2739277 · In force

Register entry

Publication number
EP2739277
Application number
EP12748097
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 3, 2012
Published
Jun 11, 2014
Granted
Nov 23, 2016
Protection ends at the latest
Aug 2, 2032
Next annual fee due
Aug 31, 2027
IPC classes
A61K 31/137 (2006.01)
A61P 3/10 (2006.01)
A61K 31/138 (2006.01)
A61K 31/661 (2006.01)
A61K 38/28 (2006.01)
A61K 45/06 (2006.01)
C07C 215/30 (2006.01)
C07F 9/09 (2006.01)
Priority
US 201161574441 P 03.08.2011
PCT application
PCT/US2012/049565 03.08.2012
PCT publication
WO2013/020069 07.02.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 3, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 03.09.2024

  4. Feb 27, 2024

    Transferred

    Owner
    Ma, Zhongmin, 2350 Lancashire Dr. Apt. 2B, Ann Arbor MI 48105, USA → REVIVALLON BIOPHARMACEUTICAL CO., LTD., Room A1907, Building 2, No. 452, Sixth Street,, Baiyangjiedao, Qiantang District,, Hangzhou City, Zhejiang Province, China

    Published in Swissreg on 27.02.2024

  5. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  6. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  7. Nov 23, 2016

    Granted

    Published in Swissreg on 23.11.2016

Parties

Holder

REVIVALLON BIOPHARMACEUTICAL CO., LTD.

Room A1907, Building 2, No. 452, Sixth Street, Baiyangjiedao, Qiantang District,, Hangzhou City, Zhejiang Province, CN

Inventor

Ma, Zhongmin

Ann Arbor MI 48105, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.